Department of Medicine, NorthShore University HealthSystem Research Institute, Evanston, IL, USA.
Department of Family Medicine, University of Chicago, Pritzker School of Medicine, Chicago, IL, USA.
J Asthma. 2020 Dec;57(12):1339-1346. doi: 10.1080/02770903.2019.1648505. Epub 2019 Aug 8.
Asthma exacerbations are associated with significant morbidity, mortality, and cost. Accurately identifying asthma patients at risk for exacerbation is essential. We sought to develop a risk prediction tool based on routinely collected data from electronic health records (EHRs). From a repository of EHRs data, we extracted structured data for gender, race, ethnicity, smoking status, use of asthma medications, environmental allergy testing BMI status, and Asthma Control Test scores (ACT). A subgroup of this population of patients with asthma that had available prescription fill data was identified, which formed the primary population for analysis. Asthma exacerbation was defined as asthma-related hospitalization, urgent/emergent visit or oral steroid use over a 12-month period. Univariable and multivariable statistical analysis was completed to identify factors associated with exacerbation. We developed and tested a risk prediction model based on the multivariable analysis. We identified 37,675 patients with asthma. Of those, 1,787 patients with asthma and fill data were identified, and 979 (54.8%) of them experienced an exacerbation. In the multivariable analysis, smoking (OR = 1.69, CI: 1.08-2.64), allergy testing (OR = 2.40, CI: 1.54-3.73), obesity (OR = 1.66, CI: 1.29-2.12), and ACT score reflecting uncontrolled asthma (OR = 1.66, CI: 1.10-2.29) were associated with increased risk of exacerbation. The area-under-the-curve (AUC) of our model in a combined derivation and validation cohort was 0.67. Despite use of rigorous methodology, we were unable to produce a predictive model with an acceptable degree of accuracy and AUC to be clinically useful.
哮喘恶化与显著的发病率、死亡率和成本有关。准确识别有哮喘恶化风险的患者至关重要。我们试图基于电子病历(EHR)中常规收集的数据开发一种风险预测工具。我们从 EHR 数据存储库中提取了有关性别、种族、民族、吸烟状况、哮喘药物使用、环境过敏测试 BMI 状况和哮喘控制测试(ACT)评分的结构化数据。确定了一个具有可用处方填充数据的哮喘患者亚组,该亚组构成了分析的主要人群。哮喘恶化定义为在 12 个月内与哮喘相关的住院治疗、紧急/紧急就诊或口服类固醇使用。完成了单变量和多变量统计分析,以确定与恶化相关的因素。我们基于多变量分析开发并测试了风险预测模型。我们确定了 37675 名哮喘患者。在这些患者中,有 1787 名哮喘患者和填充数据,其中 979 名(54.8%)经历了恶化。在多变量分析中,吸烟(OR=1.69,CI:1.08-2.64)、过敏测试(OR=2.40,CI:1.54-3.73)、肥胖(OR=1.66,CI:1.29-2.12)和反映未控制哮喘的 ACT 评分(OR=1.66,CI:1.10-2.29)与恶化风险增加相关。我们在联合推导和验证队列中的模型的曲线下面积(AUC)为 0.67。尽管使用了严格的方法,但我们无法生成具有可接受准确性和 AUC 的预测模型,使其在临床上有用。